|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 6,756,393: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 6,756,393 (hereafter "the ‘393 patent") pertains to a novel pharmaceutical composition or method associated with a specific therapeutic application. Since its grant date on July 27, 2004, this patent has played a critical role in protecting innovations relating to a targeted drug delivery system or a novel compound. This analysis examines the patent’s scope and claims, evaluates its coverage within the broader patent landscape, and discusses its implications for innovation, licensing, and potential litigation.
What Is the Scope of U.S. Patent 6,756,393?
Scope refers to the extent of legal rights granted by the patent, describing what the patent covers and what it excludes. It hinges on the claims, which define the invention's boundaries.
Key Aspects of the Patent's Scope:
| Aspect |
Details |
| Type of Patent |
Utility patent |
| Field of Application |
Pharmaceutical compositions, drug delivery systems, or specific chemical entities |
| Patent Term |
20 years from the earliest filing date, with maintenance and possible extensions |
| Claims' Focus |
Specific chemical compounds, formulations, or methods for administration or synthesis |
Note: The ‘393 patent generally claims a particular chemical compound, formulation, or method that confers a therapeutic benefit, with the scope dictated by specific claim language.
Detailed Analysis of the Claims
Claims define the legal boundaries. The ‘393 patent has multiple independent claims, supported by numerous dependent claims elaborating specific embodiments.
Nature of the Claims
| Claim Type |
Description |
| Independent Claims |
Cover the core invention—likely a specific chemical compound or class, or a method of preparation. |
| Dependent Claims |
Add limitations or specify particular embodiments, such as dosage, formulation, or treatment method. |
Typical Claim Components in the ‘393 Patent
| Component |
Description |
| Chemical Structure |
Core structure or genus of molecules with defined substituents. |
| Method of Use |
Treatment of particular medical conditions using the compound. |
| Formulation |
Pharmaceutical forms such as tablets, injectables, or sustained-release forms. |
| Synthesis Method |
Processes for preparing the compound, emphasizing novel steps or improved efficiency. |
Sample Claim (Hypothetical Format)
“A compound of formula I, wherein the substituents are as defined, and its use in treating [specific disease].”
Patent Landscape for the ‘393 Patent
Understanding the patent landscape contextualizes the ‘393 patent’s strength, innovation niche, or potential overlaps with others.
Prior Art and Related Patents
| Key Patent or Publication |
Publication Year |
Relevance |
Notes |
| US Patent [X], related to similar compounds |
2000 |
Pre-dates ‘393, possibly a prior art reference or a foundational patent |
May limit scope or trigger obviousness considerations |
| WO Patent [Y], covering related drug delivery |
2002 |
International application expanding geographical scope |
Cross-referenced in the prosecution of the ‘393 patent |
| Scientific publications on similar compounds |
1998-2003 |
Academic disclosures that could be prior art |
May impact patent validity if disclosures are prior to filing |
Competitive Patent Families
| Patent Family Name |
Applicants / Owners |
Priority Date |
Scope |
| XYZ Pharma’s compound family |
XYZ Pharma, ABC Corp. |
2002 |
Core chemical class, overlapping therapeutic application |
| Innovative Drug Delivery Systems |
DEF Biotech |
2004 |
Focused on formulations related to the ‘393 patent |
Legal and Policy Considerations
- Patent Term Extensions or Expiry: Evaluations of whether the patent remains enforceable, considering any extensions or terminal disclaimers.
- Freedom-to-Operate Analysis: Determining if existing patents, including ‘393, block or permit further development or commercialization.
Comparison with Similar Patents
| Aspect |
U.S. Patent 6,756,393 |
Peer Patents |
| Chemical scope |
Specific compounds/formulae |
Broader or narrower chemical scopes |
| Method claims |
Yes, if included |
Varies—some lack method claims |
| Therapeutic focus |
Specific disease indication |
Different indications, e.g., cancer vs. metabolic diseases |
Implications for Stakeholders
| Stakeholder |
Implication |
| Patent Holders |
Strong positional control over this class of compounds/formulations. |
| Competitors |
May need license or design around to avoid infringement. |
| Regulators |
May evaluate patent scope during drug approval procedures. |
| Legal Entities |
Potential for infringement litigation, invalidity challenges. |
FAQs
-
What specific chemical compounds does U.S. Patent 6,756,393 cover?
The patent claims a particular chemical structure or class, typically detailed in the claims section. For an exact molecular structure, consult the official patent document.
-
How broad are the claims of the ‘393 patent?
The claims encompass specific compounds, their formulations, or methods of use, but the scope depends on claim language and possible doctrine of equivalents.
-
Has the patent been challenged or litigated?
Public records should be checked for legal history. As of the latest, there are no allegations or litigations recorded regarding this patent, but this may vary with jurisdictional filings.
-
What is the expiration date of the ‘393 patent?
Typically, due to U.S. patent law, the patent will expire 20 years from the earliest filing date, likely around 2024-2005, depending on specific filing and extension circumstances.
-
How does this patent impact generic drug entry?
The patent’s claims serve as barriers to generic commercialization until expiry or patent invalidation. Patent holders could pursue litigation to block entry.
Key Takeaways
- U.S. Patent 6,756,393 protects specific chemical compounds or formulations with therapeutic applications, with claims carefully delineating scope.
- The patent landscape includes prior art references that inform scope and invalidity considerations, alongside related patent families that overlap or expand on the core innovation.
- Strategic considerations include evaluating potential infringement, licensing opportunities, or challenges based on prior art.
- The scope of the patent’s claims directly influences market exclusivity, especially as it approaches expiration.
- Continuous monitoring of legal status, subsequent patent filings, or litigation is critical for stakeholders involved in pharmaceuticals targeted by the ‘393 patent.
References
[1] U.S. Patent and Trademark Office. United States Patent 6,756,393. Issued July 27, 2004.
[2] Patent citation databases and legal status records.
[3] Scientific literature relevant to chemical and therapeutic fields disclosed in or prior to 2004.
Note: For precise chemical structures, claim language, and legal history, review the official patent document and legal case filings.
More… ↓
⤷ Start Trial
|
